Kasper CK - Search Results

1

The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience.

Brettler DB, Forsberg AD, Levine PH, Aledort LM, Hilgartner MW, Kasper CK, Lusher JM, McMillan C, Roberts H. Brettler DB, et al. Among authors: kasper ck. Arch Intern Med. 1989 Jun;149(6):1381-5. Arch Intern Med. 1989. PMID: 2499293 Clinical Trial.

2

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII.

Addiego J, Kasper C, Abildgaard C, Hilgartner M, Lusher J, Glader B, Aledort L. Addiego J, et al. Lancet. 1993 Aug 21;342(8869):462-4. doi: 10.1016/0140-6736(93)91593-b. Lancet. 1993. PMID: 8102429

3

Panel discussion on the treatment of patients with factor VIII inhibitors.

Lusher JM, Eyster ME, Hilgartner MW, Kasper CK, Mannucci PM, Nilsson IM, Penner JA, Roberts HR. Lusher JM, et al. Among authors: kasper ck. Prog Clin Biol Res. 1984;150:323-35. Prog Clin Biol Res. 1984. PMID: 6431437 No abstract available.

4

Primary pulmonary hypertension in patients with classic hemophilia.

Goldsmith GH Jr, Baily RG, Brettler DB, Davidson WR Jr, Ballard JO, Driscol TE, Greenberg JM, Kasper CK, Levine PH, Ratnoff OD. Goldsmith GH Jr, et al. Among authors: kasper ck. Ann Intern Med. 1988 Jun;108(6):797-9. doi: 10.7326/0003-4819-108-6-797. Ann Intern Med. 1988. PMID: 3130767

5

Proceedings: A more uniform measurement of factor VIII inhibitors.

Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, van Eys J, Fratantoni J, Green D, Hampton J, Hilgartner M, Levine P, Lazerson J, McMillan C, Penner J, Shapiro S, Shulman NR. Kasper CK, et al. Thromb Diath Haemorrh. 1975 Nov 15;34(2):612. Thromb Diath Haemorrh. 1975. PMID: 1198543 No abstract available.

6

Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices Committee.

Kasper CK, Lusher JM. Kasper CK, et al. Transfusion. 1993 May;33(5):422-34. doi: 10.1046/j.1537-2995.1993.33593255605.x. Transfusion. 1993. PMID: 8488548 Review. No abstract available.

7

A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group.

Lusher JM, Roberts HR, Davignon G, Joist JH, Smith H, Shapiro A, Laurian Y, Kasper CK, Mannucci PM. Lusher JM, et al. Among authors: kasper ck. Haemophilia. 1998 Nov;4(6):790-8. doi: 10.1046/j.1365-2516.1998.00209.x. Haemophilia. 1998. PMID: 10028299 Clinical Trial.

8

Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study Group.

Seremetis S, Lusher JM, Abildgaard CF, Kasper CK, Allred R, Hurst D. Seremetis S, et al. Among authors: kasper ck. Haemophilia. 1999 Jan;5(1):9-16. doi: 10.1046/j.1365-2516.1999.00191.x. Haemophilia. 1999. PMID: 10215942 Clinical Trial.

9

Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia.

Eyster ME, Whitehurst DA, Catalano PM, McMillan CW, Goodnight SH, Kasper CK, Gill JC, Aledort LM, Hilgartner MW, Levine PH, et al. Eyster ME, et al. Among authors: kasper ck. Blood. 1985 Dec;66(6):1317-20. Blood. 1985. PMID: 4063524 Free article.

10

Hepatitis A virus transmission by blood products in the United States. Transfusion Safety Study Group.

Mosley JW, Nowicki MJ, Kasper CK, Donegan E, Aledort LM, Hilgartner MW, Operskalski EA. Mosley JW, et al. Among authors: kasper ck. Vox Sang. 1994;67 Suppl 1:24-8. Vox Sang. 1994. PMID: 8091731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters